Biogen
BIIB
$291.37
Share price
-0.18%
Change (1 day)
19.95%
Change (1 year)
Categories
Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Earnings for Biogen (BIIB)
Earnings in 2022 (TTM): $3.39 B
According to Biogen's latest financial reports the company's current earnings (TTM) are $3.39 B. In 2021 the company made an earning of $1.74 B a decrease over its 2020 earnings that were of $5.04 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Biogen from 2001 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $3.39 B | 94.42% |
| 2021 | $1.74 B | -65.43% |
| 2020 | $5.04 B | -29.17% |
| 2019 | $7.12 B | 20.79% |
| 2018 | $5.89 B | 15.03% |
| 2017 | $5.12 B | 3.97% |
| 2016 | $4.93 B | 3.48% |
| 2015 | $4.76 B | 20.79% |
| 2014 | $3.94 B | 59.1% |
| 2013 | $2.48 B | 33.72% |
| 2012 | $1.85 B | 8.41% |
| 2011 | $1.71 B | 39.13% |
| 2010 | $1.22 B | -7.71% |
| 2009 | $1.33 B | 15.99% |
| 2008 | $1.14 B | 26.17% |
| 2007 | $0.91 B | 85.02% |
| 2006 | $0.49 B | 92.11% |
| 2005 | $0.25 B | 299.73% |
| 2004 | $64.09 M | -107.28% |
| 2003 | -$0.89 B | -418.38% |
| 2002 | $0.27 B | -28.99% |
| 2001 | $0.38 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.51 B | 563.69% | 🇺🇸 USA |
 Pfizer PFE | $34.92 B | 929.27% | 🇺🇸 USA |
 AbbVie ABBV | $14.78 B | 335.69% | 🇺🇸 USA |
 Amgen AMGN | $7.72 B | 127.79% | 🇺🇸 USA |
 Sanofi SNY | $8.65 B | 155.03% | 🇫🇷 France |
 Gilead Sciences GILD | $4.54 B | 33.86% | 🇺🇸 USA |
 Illumina ILMN | -$4.06 B | -219.42% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$50.48 M | -101.49% | 🇺🇸 USA |
 Qiagen QGEN | $0.62 B | -81.49% | 🇳🇱 Netherlands |
 Bio-Rad Laboratories BIO | -$7.85 B | -331.10% | 🇺🇸 USA |